Mode
Text Size
Log in / Sign up

GWAS meta-analysis finds female-specific adiposity genetics linked to endometrial cancer riskWhy does body fat affect women's cancer risk differently than men's?

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider sex-stratified adiposity genetics in endometrial cancer research; findings are mechanistic, not causal.

This genome-wide association study (GWAS) meta-analysis used genomic structural equation modelling of six adiposity GWAS, analyzing genetic data from 2 million people. The study investigated sex-stratified genetic effects of adiposity variants and their relationship to endometrial cancer risk. The primary aim was to identify sex differences in adiposity genetic effects and their link to endometrial cancer.

The analysis identified a fourfold larger female-specific causal genetic component for adiposity relative to males. It found stronger female adiposity genetic effects specifically on endometrial cancer risk, but not on other hormone-related cancers. Researchers identified 26 loci jointly associated with female adiposity and endometrial cancer, of which 16 were previously unreported. Furthermore, 14.1% of the genetic variance in endometrial cancer was found to be shared with adiposity.

This is a genetic association study identifying genetic components and pathways, not direct causation. Safety and tolerability data were not reported, as this was a genomic analysis. Key study limitations were not reported. The findings underscore the importance of sex-stratified approaches in understanding how adiposity genetics contributes to disease susceptibility, but they represent mechanistic partitions of genetic programmes, not proven clinical interventions.

We've long known that higher body weight increases a woman's risk for endometrial cancer, the most common cancer of the uterus. But why? Is it just the extra weight, or is there something fundamentally different about how a woman's body handles fat at a genetic level? A new study digging into the DNA of 2 million people offers a compelling clue: the genetic programs linking body fat to this cancer are overwhelmingly female.

The research found that the genetic component connecting adiposity—essentially, the body's fat tissue—to endometrial cancer is about four times stronger in women than in men. It's not just a general link to obesity; the effect was specific to endometrial cancer and didn't show the same strong tie to other hormone-related cancers. The scientists pinpointed 26 specific spots in the genome where genes seem to influence both female body fat and endometrial cancer risk, with 16 of those being newly discovered.

Perhaps most striking, the analysis suggests that about 14% of the genetic risk for endometrial cancer is shared with the genetics of body fat. This doesn't mean 14% of cases are caused by fat genetics—it means a significant portion of the underlying genetic blueprint overlaps. It's a powerful signal that biology is at play. However, we must be clear: this is a genetic association study. It maps shared biological pathways using complex statistical models. It identifies 'what' is connected in our DNA, not 'how' it causes cancer in a living person or what to do about it. The findings underscore that men and women are biologically different, and solving disease risk requires looking at sex separately.

What this means for you:
Genetics link body fat to endometrial cancer in a way that's uniquely female.

Study Details

EvidenceLevel 5
PublishedMar 2026
View Original Abstract ↓
Excess adiposity accounts for up to 60% of endometrial cancer cases, yet the mechanisms linking adiposity to carcinogenesis and the relevance of sex-specific adiposity genetics to disease risk have been largely unexplored. Using genomic structural equation modelling of six adiposity genome-wide association studies (GWAS), we perform the first sex-stratified adiposity common factor GWAS model, combining data from 2 million people. We identified sex differences in adiposity genetic effects and identified a fourfold larger female-specific causal genetic component relative to males. Female adiposity genetics converged on hormone-responsive and oncogenic pathways directly implicated in endometrial carcinogenesis, a specificity confirmed by stronger female adiposity genetic effects on endometrial cancer but not other hormone-related cancers. Cross-trait analysis identified 26 loci jointly associated with female adiposity and endometrial cancer, including 16 previously unreported loci. GWAS-by-subtraction revealed that only 14.1% of the genetic variance in endometrial cancer is shared with adiposity, with the remainder reflecting adiposity-independent mechanisms captured by established endometrial cancer loci. The adiposity-mediated component converged on insulin-leptin adipocyte signalling and on imprinted and pluripotency-associated developmental pathways, linked by shared nodes such as PTPN11 and PPARG. These findings recast the obesity-endometrial cancer relationship from an epidemiological observation into a mechanistically partitioned genetic programme, and underscores the importance of sex-stratified approaches to resolving how adiposity genetics contributes to disease susceptibility.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.